| Quality of life after mastectomy with or without immediate breast reconstruction J Dauplat, F Kwiatkowski, P Rouanet, E Delay, K Clough, JL Verhaeghe, ... Journal of British Surgery 104 (9), 1197-1206, 2017 | 142 | 2017 |
| The new combination docetaxel, prednisone and curcumin in patients with castration-resistant prostate cancer: a pilot phase II study H Mahammedi, E Planchat, M Pouget, X Durando, H Curé, L Guy, ... Oncology 90 (2), 69-78, 2016 | 138 | 2016 |
| Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse E Thivat, S Thérondel, O Lapirot, C Abrial, P Gimbergues, E Gadéa, ... BMC cancer 10, 1-9, 2010 | 138 | 2010 |
| Temozolomide and unusual indications: review of literature Z Tatar, E Thivat, E Planchat, P Gimbergues, E Gadea, C Abrial, ... Cancer treatment reviews 39 (2), 125-135, 2013 | 92 | 2013 |
| Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant … F Penault-Llorca, C Abrial, I Raoelfils, P Chollet, A Cayre, ... The oncologist 13 (12), 1235-1245, 2008 | 90 | 2008 |
| Therapeutic drug monitoring and tyrosine kinase inhibitors P Herviou, E Thivat, D Richard, L Roche, J Dohou, M Pouget, A Eschalier, ... Oncology letters 12 (2), 1223-1232, 2016 | 86 | 2016 |
| Dietary methionine restriction with FOLFOX regimen as first line therapy of metastatic colorectal cancer: a feasibility study X Durando, MC Farges, E Buc, C Abrial, C Petorin-Lesens, B Gillet, ... Oncology 78 (3-4), 205-209, 2010 | 74 | 2010 |
| Loss of Bcl-2 expression in colon cancer: a prognostic factor for recurrence in stage II colon cancer L Poincloux, X Durando, JF Seitz, E Thivat, VJ Bardou, MH Giovannini, ... Surgical oncology 18 (4), 357-365, 2009 | 71 | 2009 |
| Importance of metabolic changes induced by chemotherapy on prognosis of early‐stage breast cancer patients: a review of potential mechanisms E Gadea, E Thivat, E Planchat, B Morio, X Durando Obesity reviews 13 (4), 368-380, 2012 | 69 | 2012 |
| Phase II trial of the association of a methionine-free diet with cystemustine therapy in melanoma and glioma E Thivat, MC Farges, F Bacin, M D'INCAN, MA Mouret-Reynier, ... Anticancer research 29 (12), 5235-5240, 2009 | 69 | 2009 |
| Optimal methionine-free diet duration for nitrourea treatment: a Phase I clinical trial X Durando, E Thivat, MC Farges, E Cellarier, M D'Incan, A Demidem, ... Nutrition and cancer 60 (1), 23-30, 2007 | 65 | 2007 |
| A new prognostic classification after primary chemotherapy for breast cancer: residual disease in breast and nodes (RDBN) P Chollet, C Abrial, X Durando, E Thivat, O Tacca, MA Mouret-Reynier, ... The Cancer Journal 14 (2), 128-132, 2008 | 51 | 2008 |
| A methionine-free diet associated with nitrosourea treatment down-regulates methylguanine-DNA methyl transferase activity in patients with metastatic cancer E Thivat, X Durando, A Demidem, MC Farges, M Rapp, E Cellarier, ... Anticancer research 27 (4C), 2779-2783, 2007 | 43 | 2007 |
| Treatment-induced cardiotoxicity in breast cancer: a review of the interest of practicing a physical activity A Ginzac, J Passildas, E Gadéa, C Abrial, I Molnar, R Trésorier, M Duclos, ... Oncology 96 (5), 223-234, 2019 | 39 | 2019 |
| Characterisation of gut, lung, and upper airways microbiota in patients with non-small cell lung carcinoma: study protocol for case-control observational trial R Bingula, M Filaire, N Radosevic-Robin, JY Berthon, ... Medicine 97 (50), e13676, 2018 | 38 | 2018 |
| Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer J Passildas‐Jahanmohan, JC Eymard, M Pouget, F Kwiatkowski, ... Cancer Medicine 10 (7), 2332-2340, 2021 | 35 | 2021 |
| Late lines of treatment benefit survival in metastatic breast cancer in current practice? E Planchat, C Abrial, E Thivat, MA Mouret-Reynier, F Kwiatkowski, ... The Breast 20 (6), 574-578, 2011 | 32 | 2011 |
| Neutrophils are immune cells preferentially targeted by retinoic acid in elderly subjects R Minet-Quinard, MC Farges, E Thivat, C Deleine, G Mayot, J Brtko, ... Immunity & Ageing 7, 1-11, 2010 | 28 | 2010 |
| Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma J Biau, E Thivat, E Chautard, D Stefan, M Boone, B Chauffert, C Bourgne, ... Radiotherapy and Oncology 154, 227-234, 2021 | 27 | 2021 |
| Temozolomide treatment of an adult with a relapsing medulloblastoma X Durando, E Thivat, O Gilliot, B Irthum, P Verrelle, C Vincent, JO Bay Cancer investigation 25 (6), 470-475, 2007 | 27 | 2007 |
